199095
Last Update Posted: 2023-03-20
Recruiting has ended
All Genders accepted | 65 Years + |
40 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia. The regimen consists of induction phase I and II followed by cyclic consolidation cycles, reinduction and maintenance therapy
Eligibility
Relevant conditions:
Adult Acute Lymphocytic Leukemia
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov